To confirm that VVD-699 disrupts the RAS-p110α interaction in cells, we initially focused on KRAS mutant expressing H358 human lung cancer cells, which rely on KRASGly12Cys for maximal PI3K activation (16). This evidence concerns the gene PIK3CA and lung cancer.